Nine members of the HMO Research Network "will use detailed clinical profiles to search for potential subjects to enroll into … serious adverse events research projects using their electronic medical record databases," iSAEC said in a statement.
The consortium and the network will collaborate to identify genetic traits for adverse drug reactions.
The new partners include the University of Liverpool, Newcastle University, the HMO Research Network, and Cerner.
The SAEC will work with an HMO network to identify genetic variants for adverse reactions to antipsychotic medications.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.